911466-96-1 Usage
General Description
2,4-Thiazoledicarboxylic acid, 2-ethyl ester is a chemical compound with the molecular formula C6H7NO2S. It is a colorless to light yellow liquid with a pungent odor, and it is commonly used as an intermediate in the synthesis of pharmaceuticals and agricultural chemicals. 2,4-Thiazoledicarboxylic acid,2-ethyl ester is also known for its use as a chemical intermediate in the production of dyes, pigments, and other organic compounds. It is important to handle this chemical with care as it may cause skin and eye irritation upon contact, and it should be stored and disposed of properly according to safety regulations.
Check Digit Verification of cas no
The CAS Registry Mumber 911466-96-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,1,4,6 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 911466-96:
(8*9)+(7*1)+(6*1)+(5*4)+(4*6)+(3*6)+(2*9)+(1*6)=171
171 % 10 = 1
So 911466-96-1 is a valid CAS Registry Number.
911466-96-1Relevant articles and documents
NOVEL INDAZOLE COMPOUND OR SALT THEREOF
-
Paragraph 0257, (2021/09/02)
An indazole compound represented by the following Formula (I) or a salt thereof: wherein X, R1, R2, ring A, L1, L2, L3, and R5 are as defined in this specification.
METHODS OF TREATING CANCER
-
Paragraph 00429, (2020/06/10)
The present disclosure relates to methods of treating cancer in a patient using a combination of an inhibitor of an immune checkpoint protein and an indole compound or its phosphate derivative.
NOVEL FERROPORTIN INHIBITORS
-
Page/Page column 258, (2017/05/10)
The invention relates to novel ferroportin inhibitors of the general formula (I) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia and hemochromatosis.